MARZAGALLI, MONICA
MARZAGALLI, MONICA
Dipartimento di Scienze Farmacologiche e Biomolecolari
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model
2022 M. Marzagalli, G. Pelizzoni, A. Fedi, C. Vitale, F. Fontana, S. Bruno, A. Poggi, A. Dondero, M. Aiello, R. Castriconi, C. Bottino, S. Scaglione
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
2022 M. Anselmi, F. Fontana, M. Marzagalli, N. Gagliano, M. Sommariva, P. Limonta
Cancer Stem Cells—Key Players in Tumor Relapse
2021 M. Marzagalli, F. Fontana, M. Raimondi, P. Limonta
In vitro 3D cultures to model the tumor microenvironment
2021 F. Fontana, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
2021 M. Raimondi, F. Fontana, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
2020 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells
2020 F. Fontana, M. Raimondi, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Gonadotropin-releasing hormone receptors in prostate cancer : molecular aspects and biological functions
2020 F. Fontana, M. Marzagalli, M.M. Marelli, M. Raimondi, R.M. Moretti, P. Limonta
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Cellular and molecular biology of cancer stem cells in melanoma : possible therapeutic implications
2019 M. Marzagalli, M. Raimondi, F. Fontana, M. Montagnani Marelli, R.M. Moretti, P. Limonta
Mitochondria as metabolic markers of melanoma stem cells and targets of delta-tocotrienol
2019 M. Raimondi, F. Fontana, M. Marzagalli, P. Limonta
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents
2019 F. Fontana, M. Raimondi, M. Marzagalli, R.M. Moretti, M.M. Marelli, P. Limonta
Heterologous and cross-species tropism of cancer-derived extracellular vesicles
2019 M. Garofalo, A. Villa, D. Crescenti, M. Marzagalli, L. Kuryk, P. Limonta, V. Mazzaferro, P. Ciana
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
2019 P. Limonta, R.M. Moretti, M. Marzagalli, F. Fontana, M. Raimondi, M. Montagnani Marelli
Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
2019 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, P. Limonta, N. Gagliano
Anticancer properties of tocotrienols : a review of cellular mechanisms and molecular targets
2019 M. Montagnani Marelli, M. Marzagalli, F. Fontana, M. Raimondi, R.M. Moretti, P. Limonta
δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
2019 F. Fontana, R.M. Moretti, M. Raimondi, M. Marzagalli, G. Beretta, P. Procacci, P. Sartori, M. Montagnani Marelli, P. Limonta
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
2019 M. Marzagalli, N.D. Ebelt, E.R. Manuel